for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Catalent says J&J COVID-19 vaccine manufacturing facility received FDA authorization

NEW YORK, March 23 (Reuters) - Catalent Inc said on Tuesday it had received the U.S. regulatory authorization it needs to produce Johnson & Johnson’s COVID-19 vaccine at its Bloomington, Indiana facility in the United States.

Reporting by Caroline Humer Editing by Chris Reese

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up